Abstract
Interest in laser therapy as a nonhormonal option for the treatment of genitourinary syndrome of menopause (GSM) has increased. We conducted a systematic review of the use of laser therapy for the relief of GSM symptoms. Six electronic databases were searched and conference abstracts were searched manually from the introduction of laser therapy to the present date. The keywords used were: “genitourinary syndrome”, “vulvovaginal atrophy”, “postmenopausal symptoms”, “laser therapy” and “fractional laser treatment”. Of the 165 articles identified in the search, none was a randomized controlled trial. As a result, we included three observational studies without a control group and one case–control study that met our inclusion criteria. The total number of women included in the four studies was 220. The collated data suggest that laser therapy may be valuable as a nonhormonal therapeutic modality in the management of GSM. Higher quality of evidence from randomized controlled trials is required to establish the efficacy of laser treatment in the management of GSM.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Maturitas. 2014;79(3):349–354. doi:10.1016/j.maturitas.2014.07.013.
Palacios S, Mejia A, Neyro JL. Treatment of the genitourinary syndrome of menopause. Climacteric. 2015;18 Suppl 1:23–29. doi:10.3109/13697137.2015.1079100.
Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17(4):363–369. doi:10.3109/13697137.2014.899347.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–1012. doi:10.1016/j.jclinepi.2009.06.005.
Perino A, Calligaro A, Forlani F, Tiberio C, Cucinella G, Svelato A, et al. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas. 2015;80(3):296–301. doi:10.1016/j.maturitas.2014.12.006.
Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric. 2015;18(5):757–763. doi:10.3109/13697137.2015.1045485.
Salvatore S, Nappi RE, Parma M, Chionna R, Lagona F, Zerbinati N, et al. Sexual function after fractional microablative CO(2) laser in women with vulvovaginal atrophy. Climacteric. 2015;18(2):219–225. doi:10.3109/13697137.2014.975197.
Gambacciani M, Torelli MG, Martella L, Bracco GL, Casagrande AG, Albertin E, et al. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric. 2015;18 Suppl 1:43–48. doi:10.3109/13697137.2015.1071608.
Antes G, von Elm E. The PRISMA statement – what should be reported about systematic reviews? Dtsch Med Wochenschr. 2009;134(33):1619. doi:10.1055/s-0029-1233989.
Fistonic N, Fistonic I, Lukanovic A, Findri Gustek S, Sorta Bilajac Turina I, Franic D. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Climacteric. 2015;18 Suppl 1:37–42. doi:10.3109/13697137.2015.1071126.
Salvatore S, Leone Roberti Maggiore U, Athanasiou S, Origoni M, Candiani M, Calligaro A, et al. Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause. 2015;22(8):845–849. doi:10.1097/GME.0000000000000401.
Zerbinati N, Serati M, Origoni M, Candiani M, Iannitti T, Salvatore S, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2015;30(1):429–436. doi:10.1007/s10103-014-1677-2.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Rights and permissions
About this article
Cite this article
Arunkalaivanan, A., Kaur, H. & Onuma, O. Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence. Int Urogynecol J 28, 681–685 (2017). https://doi.org/10.1007/s00192-017-3282-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-017-3282-y